These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 8230753

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy.
    Huisman C, Biesma B, Postmus PE, Giaccone G, Schramel FM, Smit EF.
    Br J Cancer; 2001 Nov 16; 85(10):1456-61. PubMed ID: 11720428
    [Abstract] [Full Text] [Related]

  • 4. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Nov 16; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 5. Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network.
    Langer CJ, Millenson M, O'Dwyer P, Kosierowski R, Alexander R, Litwin S, McAleer CA, Bonjo CA, Ozols R.
    Semin Oncol; 1996 Dec 16; 23(6 Suppl 16):35-41. PubMed ID: 9007119
    [Abstract] [Full Text] [Related]

  • 6. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network.
    Langer CJ, Millenson M, Rosvold E, Litwin S, McAleer CA, Bonjo CA, Ozols R.
    Semin Oncol; 1997 Aug 16; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128
    [Abstract] [Full Text] [Related]

  • 7. Phase I study of a five-day dose schedule of 4-Ipomeanol in patients with non-small cell lung cancer.
    Kasturi VK, Dearing MP, Piscitelli SC, Russell EK, Sladek GG, O'Neil K, Turner GA, Morton TL, Christian MC, Johnson BE, Kelley MJ.
    Clin Cancer Res; 1998 Sep 16; 4(9):2095-102. PubMed ID: 9748125
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preliminary results of a phase I/II clinical trial of paclitaxel and carboplatin in non-small cell lung cancer.
    Natale RB.
    Semin Oncol; 1996 Oct 16; 23(5 Suppl 12):2-6. PubMed ID: 8941402
    [Abstract] [Full Text] [Related]

  • 11. A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
    Herbst RS, Hammond LA, Carbone DP, Tran HT, Holroyd KJ, Desai A, Williams JI, Bekele BN, Hait H, Allgood V, Solomon S, Schiller JH.
    Clin Cancer Res; 2003 Sep 15; 9(11):4108-15. PubMed ID: 14519633
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer.
    Kelly K, Pan Z, Murphy J, Huffman DH, Bunn PA.
    Clin Cancer Res; 1997 Jul 15; 3(7):1117-23. PubMed ID: 9815791
    [Abstract] [Full Text] [Related]

  • 14. Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
    Hoffman PC, Masters GA, Drinkard LC, Krauss SA, Samuels BL, Golomb HM, Vokes EE.
    Semin Oncol; 1996 Jun 15; 23(3 Suppl 6):11-5. PubMed ID: 8677441
    [Abstract] [Full Text] [Related]

  • 15. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA, Drinkard LC, Hoffman PC, Lane N, Watson S, Samuels BL, Bitran JD, Golomb HM, Vokes EE.
    Cancer J Sci Am; 1995 Jun 15; 1(4):288-94. PubMed ID: 9166490
    [Abstract] [Full Text] [Related]

  • 16. Phase I dose-escalation trial of paclitaxel and ifosfamide in patients with advanced non-small cell lung cancer.
    Shepherd FA, Latreille J, Paul K, Eisenhauer E.
    Semin Oncol; 1996 Dec 15; 23(6 Suppl 16):84-90. PubMed ID: 9007130
    [Abstract] [Full Text] [Related]

  • 17. Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer.
    Mantovani G, Macciò A, Mulas C, Massa E, Madeddu C, Mura L, Contu P, Versace R.
    Oncol Rep; 2002 Dec 15; 9(3):661-70. PubMed ID: 11956647
    [Abstract] [Full Text] [Related]

  • 18. Paclitaxel and carboplatin: a phase I study in advanced non-small cell lung cancer.
    Paccagnella A, Favaretto A, Oniga F, Ossana L.
    Semin Oncol; 1996 Dec 15; 23(6 Suppl 16):76-9. PubMed ID: 9007128
    [Abstract] [Full Text] [Related]

  • 19. Phase I-II study of high-dose epirubicin in advanced non-small-cell lung cancer.
    Feld R, Wierzbicki R, Walde PL, Shepherd FA, Evans WK, Gupta S, Shannon P, Lassus M.
    J Clin Oncol; 1992 Feb 15; 10(2):297-303. PubMed ID: 1310105
    [Abstract] [Full Text] [Related]

  • 20. Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II study.
    Stathopoulos GP, Rigatos SK, Christodoulou C, Malamos NA, Deliyiannis F, Stathopoulos JG, Skarlos DV.
    Cancer Chemother Pharmacol; 2004 Sep 15; 54(3):259-64. PubMed ID: 15127231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.